RESOURCES | Cannabis Securities News

CRB Monitor Cannabis-Linked Securities July 2021 Update
Published on August 30, 2021


CRB Monitor Cannabis-Linked Securities July 2021 Update

James B. Francis, CFA
Chief Research Officer, CRB Monitor

CRB Monitor tracks ~ 1,400 publicly-traded, Cannabis-Related Businesses (CRBs) globally, which have ~1,600 traded securities.  We categorize CRBs into our proprietary cannabis risk tier framework and cannabis-linked (CLS) sectors.  In addition, CRB Monitor unravels and maintains complex corporate structures, linking publicly-traded parent companies to their underlying operational plant-touching subsidiaries. Custodian banks, broker/dealers, and asset managers find our data essential for pre-trade compliance, risk management, index construction, and portfolio analytics.  

CRB Monitor Securities Database Updates 

In 2021, CRB Monitor’s research team made more than 1,100 updates to securities’ information and added more than 5,000 source documents and relevant news articles to the CRB Monitor database.  Here is a summary of the updates for July 2021:


Cannabis News Updates: M&A

The cannabis M&A train kept rolling in the month of July as CRB Monitor research identified mergers and acquisitions that resulted in 48 new subsidiary relationships for publicly-traded CRBs.  

Tier 1B CRB Green Thumb Industries Inc. (CSE: GTII) expanded its US cannabis “thumb” print in July by establishing operations in Virginia with the closing of its acquisition of grower/processor/retailer Dharma Pharmaceuticals.  This purchase broadens GTII’s presence in the US to 14 states and increases its subsidiaries’ total number of active cannabis licenses to 188.

Kiaro Holdings Corp. (TSXV: KO), a Tier 1B Canadian CRB added 7 newly-licensed Tier 1A retail locations in Ontario while securing an opening into distribution in Australia.  Now operating in British Columbia, Ontario, and Saskatchewan, these acquisitions bring Kiaro’s active license total (all recreational cannabis) to 23.  What’s also interesting about this transaction is that it includes the creation of “a new digital portfolio focused on the supply of high-quality consumption accessories to Canadian, American and Australian consumers,” according to a July press release.

In July, top 20 Tier 1A Sundial Growers Inc. (NASDAQ: SNDL), completed its acquisition of all the issued and outstanding shares of Spirit Leaf Retail Cannabis Network, aka Inner Spirit Holdings Ltd.  This was a significant move for Sundial, which broadened and deepened its product set as well as diversified its presence, particularly in Canada.  This acquisition expanded Sundial’s presence by 88 medical and retail licenses across 5 provinces and, in the words of Sundial’s PR department “establishes Sundial as one of Canada's largest vertically integrated cannabis companies.” 

And we’d be remiss if we failed to mention the latest news regarding Tier 1B Verano Holdings Corp. (CSE: VRNO).  In a continuation of the growth of its footprint in the medical and recreational cannabis market, Verano announced the opening of its 80th dispensary in the US, located in Pittsburgh and featuring Pennsylvania’s first drive-through service.  Per the CRB Monitor database, this brings Verano’s active and pending license count to 130 across 18 states in the US.


Select M&A/Subsidiary Highlights:


Ticker Symbol



Radient Technologies Inc.


Tier 1A

Radient Technologies Inc. Enters into Binding Letter of Intent to Acquire Tunaaaa Room Xtracts Inc.

Green Thumb Industries Inc.


Tier 1B

Green Thumb Industries Closes on Acquisition of Dharma Pharmaceuticals; Enters Virginia Cannabis Market

Icanic Brands Company Inc.


Tier 1B

Icanic Brands Closes Acquisition of De Krown Enterprises LLC

Trulieve Cannabis Corp.


Tier 1B

Trulieve Completes Acquisition of Keystone Shops in Pennsylvania

Kiaro Holdings Corp.


Tier 1B

Kiaro Acquires Cozy Cannabis and Enters Ontario With a Premier Toronto Location, and adds US and Australia Focused Ecommerce

Harvest Health & Recreation, Inc.


Tier 1A

Harvest Health & Recreation Inc. Announces Divestiture of Utah Assets

Jushi Holdings Inc.


Tier 1B

Jushi Holdings Inc. Completes Acquisition of Licensed Cultivator in Ohio

Sundial Growers Inc.


Tier 1A

Sundial Growers Completes the Acquisition of Spiritleaf Retail Cannabis Network

Verano Holdings Corp.


Tier 1B

Verano Affiliate Announces Opening of Flagship Pittsburgh Dispensary with Western Pennsylvania's First Drive-Through


Security/Exchange Highlights:


Company Name

Ticker Symbol



WeedMD Inc.


Name Change

WeedMD Inc. Announces Intent to Change Corporate Name to Entourage Health Corp.

Choom Holdings Incorporated


New Listing

CSE Bulletin: New Listing - Choom Holdings Inc. Warrants (CHOO.WT)

MYM Nutraceuticals Inc.



CSE Bulletin: Delist - MYM Nutraceuticals Inc. (MYM)

Pharmadrug Inc.


New Symbol

PharmaDrug Announces Stock Ticker Symbol Change to (CSE: PHRX)

AgraFlora Organics International Inc.


ID/Name Change

AgraFlora Organics International Inc. Changing Name to Agra Ventures Ltd.

GTEC Holdings Ltd.


New Listing

Avant Brands to Graduate to OTCQX® Best Market

Ascend Wellness Holdings, Inc.


New Listing

AWH Announces Commencement of Trading on the OTCQX in the United States

Cansortium Inc.


New Listing

OTC Markets Group Welcomes Cansortium to OTCQX



Select New Additions to CRB Monitor:


Ticker Symbol


CRBM Cannabis Sector (CLS)

Soaring Eagle Acquisition Corp.


Tier 2

Financial Services

Verde Resources, Inc.


Tier 3

Pharma & Biotech

Hempsana Holdings Ltd.


Tier 1B


CEN Biotech, Inc.


Tier 1B


Clover Leaf Capital Corp.


Tier 2

Financial Services



Regulatory Updates

In mid-July 2021, Senate Majority Leader Chuck Schumer (D–NY), Senate Finance Committee Chairman Ron Wyden, (D-OR) and Senator Cory Booker (D-NJ) released a draft version of a bill that would effectively and permanently legalize marijuana in the United States.  The bill, officially named the Cannabis Administration and Opportunity Act, is a comprehensive piece of legislation that if passed, would pave the way for the future of the cannabis industry while providing benefits to underserved communities as well.  Quoting from the 30-page summary document

“Today, more than 90 percent of Americans believe cannabis should be legal either for adult or medical use. Despite legalization under state law and broad public support for cannabis legalization, cannabis remains illegal under federal law.  By ending the failed federal prohibition of cannabis, the Cannabis Administration and Opportunity Act will ensure that Americans – especially Black and Brown Americans – no longer have to fear arrest or be barred from public housing or federal financial aid for higher education for using cannabis in states where it’s legal.”

This sweeping bill, if it were to pass and be signed by the President, would:

  • Remove marijuana from the Controlled Substances Act within 60 days of the bill’s enactment
  • Expunge marijuana-related arrest records
  • Reinvest in communities most harmed by the drug war
  • Maintain the authority of states to set their own marijuana policies
  • Impose a federal tax on marijuana products and put some of that revenue toward grant programs for people from underserved communities to participate in the industry
  • Transfer regulatory authority over cannabis from the Drug Enforcement Administration (DEA) to the Food and Drug Administration (FDA), the Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) and the Alcohol and Tobacco Tax and Trade Bureau (TTB)

As we have stated in the past, this legislation faces its share of obstacles.  While the US House of Representatives appears to have the votes to pass a version of this bill, there are barriers to its passage both in the Senate and in the Executive branch, which has been firmly opposed to cannabis legalization since prior to the 2020 election.  As always, stay tuned, as this story is far from over!

Cannabis-linked Equity Performance 

Source: CRB Monitor, Sentieo

We can see on the chart above how things have played out for the more significant players over the last 24 months of returns.  It’s reasonable to assume that the larger, household-name CRBs – Tilray, Inc. (Nasdaq: TLRY) (-64%), Cronos Group Inc. (TSX: CRON) (-55%), and Canopy Growth Corporation (TSX: WEED) (-47%) – have done quite a bit of taking with very little giving over this period and investors should take note.  In spite of the February 2021 spike, these three marquis CRBs, with their ambitious corporate strategies, have not delivered value for their shareholders and their performance has proven this out. 

Conversely, for investors that chose wisely over the last two years their bets have paid off.  Risk notwithstanding, High Tide Inc. (CSE: HITI) (+173%), Trulieve Cannabis Corp. (CSE: TRUL) (+195%), and Green Thumb Industries Inc. (CSE: GTII ) (+194%) have rewarded investors by implementing successful growth-driven strategies, particularly with expansion of operations throughout the United States.  We should note that these three CRBs are companies with their primary listings on the CSE, and they all have a direct connection to the production and sale of US marijuana.  Meanwhile, TLRY, CRON, and WEED have intentionally conducted their direct marijuana operations outside of the US, which has allowed them to list on TSX and Nasdaq.  It would appear that this strategy has been a disappointment over the last 2 years for their shareholders.


[One final note on longer term performance: For investors in an equally-weighted, diversified index of the top 10 pure play CRBs, the 2-year performance through July 2021 has been a respectable 51%.]

Cannabis equities tended to underperform mainstream equities in July 2021, in an apparent protracted correction that followed a brief, but significant rally in early February.  Are we seeing the makings of another prolonged selloff, similar to what we witnessed beginning back in April 2019?  This could be the case, given the ongoing regulatory gridlock at the federal level (see news analysis above) and cannabis companies’ apparent inability to deliver consistent profits over an extended period of time.  Or have the larger players (i.e. Tilray) overextended themselves via their blockbuster acquisitions, leaving too little cash on the balance sheet to weather another wave of the pandemic and subsequent economic turndown?  Once again, stay tuned for future developments.

The CRB Monitor index of Top 10 pure play CRBs (equally weighted) had a return of -12.1% for July 2021, with all 10 constituents in negative territory for the month.  The Top 10 index underperformed major domestic and global indexes (SPX, EAFE, and EMF) for July.

CRB Monitor “Top 10” Tier 1 Cannabis Companies – July 2021

Source: CRB Monitor, Sentieo



CRBs In the News 

The following is a sampling of highlights from the July 2021 cannabis news cycle, as tracked by CRB Monitor.  Included are CRB Monitor’s proprietary Risk Tiers

Wondering what a Tier 1, Tier 2 or Tier 3 CRB is?

See our seminal ACAMS Today white paper Defining "Marijuana-Related Business" and its update Defining "Cannabis-Related Business"


Most Popular

Subscribe For Updates

Explore how CRBMonitor can simplify your cannabis-related compliance challenges.